Literature DB >> 10622710

Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes.

O Aguilera1, H Ostolaza, L M Quirós, J F Fierro.   

Abstract

A synthetic peptide (23 residues) that includes the antibacterial and lipopolysaccharide-binding regions of human lactoferricin, an antimicrobial sequence of lactoferrin, was used to study its action on cytoplasmic membrane of Escherichia coli 0111 and E. coli phospholipid vesicles. The peptide caused a depolarization of the bacterial cytoplasmic membrane, loss of the pH gradient, and a bactericidal effect on E. coli. Similarly, the binding of the peptide to liposomes dissipated previously created transmembrane electrical and pH gradients. The dramatic consequences of the transmembrane ion flux during the peptide exposure indicate that the adverse effect on bacterial cells occurs at the bacterial inner membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622710     DOI: 10.1016/s0014-5793(99)01545-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.

Authors:  Howard N Hunter; A Ross Demcoe; Håvard Jenssen; Tore J Gutteberg; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 2.  The role of membrane tension in the action of antimicrobial peptides and cell-penetrating peptides in biomembranes.

Authors:  Moynul Hasan; Md Mizanur Rahman Moghal; Samiron Kumar Saha; Masahito Yamazaki
Journal:  Biophys Rev       Date:  2019-05-15

3.  Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.

Authors:  L Håversen; N Kondori; L Baltzer; L A Hanson; G T Dolphin; K Dunér; I Mattsby-Baltzer
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

5.  Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.

Authors:  C H Chilton; G S Crowther; K Śpiewak; M Brindell; G Singh; M H Wilcox; T M Monaghan
Journal:  J Antimicrob Chemother       Date:  2016-01-11       Impact factor: 5.790

6.  Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076.

Authors:  Nataly De Jesús Huertas Méndez; Yerly Vargas Casanova; Anyelith Katherine Gómez Chimbi; Edith Hernández; Aura Lucia Leal Castro; Javier Mauricio Melo Diaz; Zuly Jenny Rivera Monroy; Javier Eduardo García Castañeda
Journal:  Molecules       Date:  2017-03-12       Impact factor: 4.411

7.  Antimicrobial lactoferrin peptides: the hidden players in the protective function of a multifunctional protein.

Authors:  Mau Sinha; Sanket Kaushik; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  Int J Pept       Date:  2013-02-13

8.  The prospects of modifying the antimicrobial properties of milk.

Authors:  A F Kolb
Journal:  Biotechnol Adv       Date:  2001-07       Impact factor: 14.227

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.